Keywords: Daxas, UK, NICE, Merck & Co, Nycomed, COPD, Draft guidance

Draft guidance from UK's NICE recommends clinical trial for COPD drug Daxas

Article | 09 September 2011

Print This

New draft guidance from the UK's drug watchdog the National Institute for Health and Clinical Excellence (NICE) recommends the use ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in